AI health tech for echocardiography-based detection of heart failure and cardiac amyloidosis.
| Date | Round | Amount |
|---|---|---|
| Jul 2025 | Series C Ultromics raised a $55M Series C led by Lightrock, L&G and Allegis Capital to expand its AI heart-disease diagnostics. | $55M |
| Aug 2021 | Series B Oxford cardiology-AI company Ultromics raised a USD 33M Series B led by the Blue Venture Fund. | $33M |